Steroid receptor coactivators: Servants and masters for control of systems metabolism

Trends in Endocrinology and Metabolism

Volumn 25, Issue 7, 2014, Pages 337-347

  Stashi, Erin ^a   York, Brian ^a   O'Malley, Bert W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Coregulator; Metabolism; Nuclear receptor; Steroid receptor coactivator; Transcription

Indexed keywords

NUCLEAR RECEPTOR COACTIVATOR 2; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3;

AMINO ACID METABOLISM; CARBOHYDRATE METABOLISM; HOMEOSTASIS; HUMAN; LIPID METABOLISM; LIVER; METABOLIC REGULATION; METABOLISM; MUSCLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEROID METABOLISM; XENOBIOTIC METABOLISM; ANIMAL;

ANIMALS; HUMANS; NUCLEAR RECEPTOR COACTIVATOR 1; NUCLEAR RECEPTOR COACTIVATOR 2; NUCLEAR RECEPTOR COACTIVATOR 3;

EID: 84903450420     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2014.05.004     Document Type: Review

References (85)

1. York B., O'Malley B.W. Steroid receptor coactivator (SRC) family: masters of systems biology. J. Biol. Chem. 2010, 285:38743-38750.
2. Xu J., et al. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat. Rev. Cancer 2009, 9:615-630.
3. Dasgupta S., et al. Nuclear receptor coactivators: master regulators of human health and disease. Annu. Rev. Med. 2013, 65:279-292.
4. Walsh C.A., et al. The function of steroid receptor coactivator-1 in normal tissues and cancer. Int. J. Biol. Sci. 2012, 8:470-485.
5. Han S.J., et al. A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis. Nat. Med. 2012, 18:1102-1111.
6. Qin L., et al. The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis. Cancer Res. 2009, 69:3819-3827.
7. Gehin M., et al. The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol. Cell. Biol. 2002, 22:5923-5937.
8. Taylor B.S., et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010, 18:11-22.
9. Shiota M., et al. Peroxisome proliferator-activated receptor coactivator-1 interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR. Mol. Endocrinol. 2009, 24:114-127.
10. Xu J., et al. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6379-6384.
11. Osborne C.K., et al. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J. Natl. Cancer Inst. 2003, 95:353-361.
12. Picard F., et al. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 2002, 111:931-941.
13. Coste A., et al. The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1α. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:17187-17192.
14. Murakami K., et al. Fatty-acyl-CoA thioesters inhibit recruitment of steroid receptor co-activator 1 to alpha and gamma isoforms of peroxisome-proliferator-activated receptors by competing with agonists. Biochem. J. 2001, 353:231-238.
15. Miard S., et al. Aging alters PPARγ in rodent and human adipose tissue by modulating the balance in steroid receptor coactivator-1. Aging Cell 2009, 8:449-459.
16. Wang Z., et al. Critical roles of the p160 transcriptional coactivators p/CIP and SRC-1 in energy balance. Cell Metab. 2006, 3:111-122.
17. Hartig S.M., et al. Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis. J. Cell Biol. 2011, 192:55-67.
18. York B., et al. Research resource: tissue- and pathway-specific metabolomic profiles of the steroid receptor coactivator (SRC) Family. Mol. Endocrinol. 2013, 27:366-380.
19. Stashi E., et al. SRC-2 is an essential coactivator for orchestrating metabolism and circadian rhythm. Cell Rep. 2014, 6:633-645.
20. Chopra A.R., et al. Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption. Cell Metab. 2011, 13:35-43.
21. Ma X., et al. Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis. J. Hepatol. 2011, 55:445-452.
22. Ma X., et al. Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis. Lab. Invest. 2009, 89:903-914.
23. Duteil D., et al. The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles. Cell Metab. 2010, 12:496-508.
24. York B., et al. Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy. Cell Metab. 2012, 15:752-763.
25. Jeong J-W. The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism. Mol. Endocrinol. 2006, 20:1138-1152.
26. Louet J-F., et al. The coactivator SRC-1 is an essential coordinator of hepatic glucose production. Cell Metab. 2010, 12:606-618.
27. +/NADH homeostasis. Mol. Endocrinol. 2014, 28:395-405.
28. Yan J., et al. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Cancer Res. 2006, 66:11039-11046.
29. Liao L., et al. Steroid receptor coactivator 3 maintains circulating insulin-like growth factor I (IGF-I) by controlling IGF-binding protein 3 expression. Mol. Cell. Biol. 2008, 28:2460-2469.
30. York B., et al. Reprogramming the posttranslational code of SRC-3 confers a switch in mammalian systems biology. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11122-11127.
31. Wang Z., et al. The transcriptional coactivators p/CIP and SRC-1 control insulin resistance through IRS1 in obesity models. PLoS ONE 2012, 7:e36961.
32. Chopra A.R., et al. Absence of the SRC-2 coactivator results in a glycogenopathy resembling von Gierke's disease. Science 2008, 322:1395-1399.
33. (null) et al. A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E1377-E1386.
34. Kommagani R., et al. Acceleration of the glycolytic flux by steroid receptor coactivator-2 is essential for endometrial decidualization. PLoS Genet. 2013, 9:e1003900.
35. Reineke E.L., et al. SRC-2 coactivator deficiency decreases functional reserve in response to pressure overload of mouse heart. PLoS ONE 2012, 7:e53395.
36. Asakura M., Kitakaze M. Global gene expression profiling in the failing myocardium. Circ. J. 2009, 73:1568-1576.
37. Wang H., Tompkins L.M. CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. Curr. Drug Metab. 2008, 9:598-610.
38. Hsieh H-T., et al. PIASy inhibits LRH-1-dependent CYP11A1 expression by competing for SRC-1 binding. Biochem. J. 2009, 419:201.
39. Xu P.L. Molecular mechanism for the potentiation of the transcriptional activity of human liver receptor homolog 1 by steroid receptor coactivator-1. Mol. Endocrinol. 2004, 18:1887-1905.
40. Martinez-Jimenez C.P. Underexpressed coactivators PGC1 AND SRC1 impair hepatocyte nuclear factor 4 function and promote dedifferentiation in human hepatoma cells. J. Biol. Chem. 2006, 281:29840-29849.
41. Martinez-Jimenez C.P., et al. Transcriptional activation of CYP2C9, CYP1A1, and CYP1A2 by hepatocyte nuclear factor 4 requires coactivators peroxisomal proliferator activated receptor-coactivator 1 and steroid receptor coactivator 1. Mol. Pharmacol. 2006, 70:1681-1692.
42. Muangmoonchai R., et al. Xenobiotic induction of cytochrome P450 2B1 (CYP2B1) is mediated by the orphan nuclear receptor constitutive androstane receptor (CAR) and requires steroid co-activator 1 (SRC-1) and the transcription factor Sp1. Biochem. J. 2001, 355:71-78.
43. Takeshita A., et al. Mitotane induces CYP3A4 expression via activation of the steroid and xenobiotic receptor. J. Endocrinol. 2013, 216:297-305.
44. Chen T., et al. SRC-3 is required for CAR-regulated hepatocyte proliferation and drug metabolism. J. Hepatol. 2012, 56:210-217.
45. Lachize S., et al. Steroid receptor coactivator-1 is necessary for regulation of corticotropin-releasing hormone by chronic stress and glucocorticoids. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:8038-8042.
46. Winnay J.N. Steroid receptor coactivator-1-deficient mice exhibit altered hypothalamic-pituitary-adrenal axis function. Endocrinology 2005, 147:1322-1332.
47. Zalachoras I., et al. Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:7910-7915.
48. Stashi E., et al. Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences. Mol. Endocrinol. 2013, 27:1776-1787.
49. Zhu L., et al. Steroid receptor coactivator-1 mediates estrogenic actions to prevent body weight gain in female mice. Endocrinology 2012, 154:150-158.
50. Patchev A.V., et al. Insidious adrenocortical insufficiency underlies neuroendocrine dysregulation in TIF-2 deficient mice. FASEB J. 2006, 21:231-238.
51. Gupte R., et al. Glucocorticoid receptor represses proinflammatory genes at distinct steps of the transcription cycle. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:14616-14621.
52. Chinenov Y., et al. Role of transcriptional coregulator GRIP1 in the anti-inflammatory actions of glucocorticoids. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:11776-11781.
53. Uhlenhaut N.H., et al. Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol. Cell 2013, 49:158-171.
54. An B-S., et al. Steroid receptor coactivator-3 is required for progesterone receptor trans-activation of target genes in response to gonadotropin-releasing hormone treatment of pituitary cells. J. Biol. Chem. 2006, 281:20817-20824.
55. Paramanik V., Thakur M.K. AIB1 shows variation in interaction with ERβTAD and expression as a function of age in mouse brain. Biogerontology 2011, 12:321-328.
56. Percharde M., et al. Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes Dev. 2012, 26:2286-2298.
57. Son Y.L., Lee Y.C. Molecular determinants of the interactions between SRC-1 and LXR/RXR heterodimers. FEBS Lett. 2010, 584:3862-3866.
58. Mascrez B., et al. Ligand-dependent contribution of RXRβ to cholesterol homeostasis in Sertoli cells. EMBO Rep. 2004, 5:285-290.
59. Wang Z., Burke P.A. Modulation of hepatocyte nuclear factor-4α function by the peroxisome-proliferator-activated receptor-γ co-activator-1α in the acute-phase response. Biochem. J. 2008, 415:289.
60. Kim M.S., et al. Tumor necrosis factor and interleukin 1 decrease RXRα, PPARα, PPARγ, LXRα, and the coactivators SRC-1, PGC-1α, and PGC-1β in liver cells. Metabolism 2007, 56:267-279.
61. Wang Y. Downregulation of liver X receptor in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines. J. Lipid Res. 2005, 46:2377-2387.
62. Musille P.M., et al. Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation. Nat. Struct. Mol. Biol. 2012, 19:532-537.
63. Wang Y., et al. A second class of nuclear receptors for oxysterols: regulation of RORα and RORγ activity by 24S-hydroxycholesterol (cerebrosterol). Biochim. Biophys. Acta 2010, 1801:917-923.
64. Voight B.F., et al. A map of recent positive selection in the human genome. PLoS Biol. 2006, 4:e72.
65. Lonard D.M., O'Malley B.W. Nuclear receptor coregulators: modulators of pathology and therapeutic targets. Nat. Rev. Endocrinol. 2012, 8:598-604.
66. Hardie D.G., et al. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012, 13:251-262.
67. Steinberg G.R., Kemp B.E. AMPK in health and disease. Physiol. Rev. 2009, 89:1025-1078.
68. Wang Y., et al. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. Mol. Endocrinol. 2011, 25:2041-2053.
69. Wang Y., et al. Bufalin is a potent small molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Res. 2014, 74:1506-1517.
70. Spelsberg T.C., et al. Progesterone-binding components of chick oviduct III. Chromatin acceptor sites. J. Biol. Chem. 1971, 246:4188-4197.
71. Murray M.B., Towle H.C. Identification of nuclear factors that enhance binding of the thyroid hormone receptor to a thyroid hormone response element. Mol. Endocrinol. 1989, 3:1434-1442.
72. Ma J., Ptashne M. Converting a eukaryotic transcriptional inhibitor into an activator. Cell 1988, 55:443-446.
73. Dynlacht B.D., et al. Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation. Cell 1991, 66:563-576.
74. Luo Y., et al. A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell 1992, 71:231-241.
75. Vegeto E., et al. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 1992, 69:703-713.
76. Allan G.F., et al. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 1992, 267:19513-19520.
77. McDonnell D.P., et al. Identification of a novel negative regulator of steroid receptor function. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:10563-10567.
78. Kwok R.P., et al. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994, 370:223-226.
79. Halachmi S., et al. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 1994, 264:1455-1458.
80. Baniahmad A., et al. The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol. Cell. Biol. 1995, 15:76-86.
81. Kurokawa R., et al. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 1995, 377:451-454.
82. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995, 377:454-457.
83. Oñate S.A., et al. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995, 270:1354-1357.
84. O'Malley B.W. Coregulators: from whence came these 'master genes'. Mol. Endocrinol. 2007, 21:1009-1013.
85. Malovannaya A., et al. Analysis of the human endogenous coregulator complexome. Cell 2011, 145:787-799.